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Objectives. The value of 99mTc-sestamibi (2-methoxy-isobutyl
isonitrile [MIBI]) as a viability tracer was investigated in patients
undergoing coronary artery bypass graft surgery.
Background. Initial studies claim that rest MIBI single-photon
emission computed tomographic (SPECT) studies can be used to
assess myocardial viability.
Methods. Thirty patients with a severely stenosed left anterior
descending coronary artery and wall motion abnormalities were
prospectively included. The patients underwent a MIBI rest study,
a positron emission tomographic (PET) flow (13NH3) and metab-
olism (18F-deoxyglucose) study and nuclear angiography before
undergoing bypass surgery. A preoperative transmural biopsy
specimen was taken from the left ventricular anterior wall.
Morphometry was performed to assess percent fibrosis. After 3
months, radionuclide angiography was repeated.
Results. Statistically significant higher MIBI values were found
in the group with myocardial viability as assessed by PET than in
the group with PET-assessed nonviability (p < 0.01). Significantly
higher MIBI values were found in the group with enhanced
contractility at 3 months (76 6 13% vs. 53 6 22%, p < 0.01). A
linear relation was found between MIBI uptake and percent
fibrosis in the biopsy specimen (r 5 0.78, p < 0.00001). When
maximizing the threshold for assessment of viability with MIBI by
using functional improvement as the reference standard, a cutoff
value of 50% was found, with positive and negative predictive
values of 82% and 78%, respectively.
Conclusions. 99mTc MIBI uptake was significantly higher in
PET-assessed viable areas and in regions with enhanced contrac-
tility at 3 months. A linear relation was found between percent
fibrosis and MIBI uptake. An optimal threshold of 50% was found
for prediction of functional recovery.
(J Am Coll Cardiol 1997;29:62–8)
q1997 by the American College of Cardiology
Positron emission tomography (PET) is known to accurately
identify viable tissue in chronically ischemic myocardium (1–
5). The principal limitations of PET imaging are the high
costs of the equipment and the on site production of radio-
chemicals. Viability of myocardium can also be studied with
high accuracy by using 201Tl imaging reinjection or redistribu-
tion protocols (6–9). The possible role of 99mTc-sestamibi
(2-methoxy-isobutyl isonitrile [MIBI]) is not clearly demon-
strated in this context. Initial studies (10,11) claimed that
rest MIBI single-photon emission computed tomographic
(SPECT) studies could be used to obtain information on
myocardial viability. More recently (12), quantified MIBI
activity 1 h after injection was stated to be similar to redistri-
bution 201Tl activity, thus suggesting that MIBI is more than
a pure flow tracer. The aim of this study was to assess the
value of 99mTc MIBI as a viability tracer in patients with
known coronary artery disease undergoing coronary artery
bypass surgery and to correlate the findings in quantitative
MIBI SPECT images with those of PET images and with
quantitative histologic findings in biopsy specimens. For this
purpose, patients with chronic coronary artery disease (CAD)
and regional myocardial dysfunction undergoing bypass
surgery were studied. Patients with left anterior descending
coronary artery (LAD) disease were chosen so that a transmu-
ral biopsy specimen from the anterior free wall could be
obtained easily without additional manipulation of the pa-
tient’s heart.
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Methods
Patient selection. Patients with known CAD, one- or two-
vessel disease, an occlusion or severe stenosis ($70%) of the
LAD and anterior wall motion abnormalities were included
prospectively. Patients with diabetes mellitus were excluded.
The study protocol was granted approval by the ethical com-
mittee of the hospital (UZ Gasthuisberg, Leuven, Belgium).
The same protocol for patient selection was used for other
purposes in previous studies performed by our laboratory
(13,14). No patient in this study has been previously reported
on.
Coronary angiography and contrast ventriculography. All
patients underwent contrast ventriculography and coronary
angiography with the Sones technique within 8 weeks before
operation. The ventriculograms and angiograms were visually
interpreted by two experienced readers using the following
scoring system: 15 normokinesia; 25 hypokinesia; 35 severe
hypokinesia, 45 akinesia or dyskinesia. Interobserver variabil-
ity was low, as the reviewers’ scores differed for only two
patients. A third reader scored the left ventriculograms in
these patients and consensus was reached with the two other
readers. Patients with severe stenosis of the LAD ($70%) and
hypokinesia, akinesia or dyskinesia on X-ray left ventricular
angiography underwent radionuclide angiography.
Radionuclide angiography. One day before and 3 months
after operation, nuclear angiography was performed for eval-
uation and follow-up of global and regional left ventricular
function. Ten minutes after injection of 20 mCi of 99mTc-
labeled red blood cells, equilibrium gated nuclear angiography
was performed during 10 min while the patient was positioned
under the gamma camera in a 458 left anterior oblique
position. A low energy, all purpose collimator was used. The
same study was repeated in a 708 left anterior oblique and an
anterior position. Global and regional ejection fractions (EFs)
were calculated by using standard software (Sopha Medical
Benelux, Brussels, Belgium). End-diastolic and end-systolic
regions of interest (ROIs) were determined automatically by
convolving the end-diastolic image and a cycle summation
image with an edge-enhancing kernel in the horizontal, vertical
and two diagonal directions. Two binary images are produced
that contain the positions of local maximums after each pass,
yielding a closed border image after four passes. In these
images, the left ventricular border is tracked to separate it
from other outlined structures. The tracking starting point is
the first border point to the right of the center of mass in a
calculated contraction amplitude image. The final left ventric-
ular ROI is the intersection of ROIs in both images (15,16). To
calculate global EF, a background region is determined auto-
matically as a ROI next to the free ventricular wall, following
the outline of the left ventricular ROI. Background correction
is done by simple subtraction. Global EF is calculated as
End-diastolic volume2 End-systolic volume/End-diastolic vol-
ume. To calculate regional EF, background correction is done
by quadratic interpolation to compensate for nonhomoge-
neous tissue cross talk from the right ventricle, outflow tract
and atrial appendages. Because no anatomic landmarks are
visible in scintigraphic studies, the end-diastolic ROI is divided
into eight “pie-shaped” sectors by using the center of mass of
the end-diastolic left ventricular ROI as a center. The center
remains the same during the whole cardiac cycle. The regions
use overlapping image information (a region also uses half of
the two adjacent regions). Regional EF is calculated by using
the regional analog of End-diastolic volume 2 End-systolic
volume/End-diastolic volume (15). The software was validated
with 88 gated blood pool data sets from the Mayo Clinic
against results obtained from the Mayo Clinic by their experi-
enced technologists with their own software (y 5 0.87x 1 6.2,
r 5 0.92, x 5 Mayo Clinic software, y 5 Sopha program,
SEE 5 5.5, n 5 88). Normal values for regional anterior EF
with our software are 72 6 5%. Regional function was
considered to have improved if regional EF in the anterior wall
was 5% higher at 3 months.
PET studies. In each patient, myocardial blood flow and
metabolism were measured with PET 1 or 2 days before
revascularization. The perfusion/metabolism studies were per-
formed with a whole body positron emission tomograph (mod-
el 931-08/12, CTI Siemens). Before each study, a 2-min
rectilinear scan, used to position the heart within the field of
view, was followed by a 15-min transaxial transmission scan by
using a 68Ge ring source for photon attenuation correction.
Myocardial perfusion was evaluated by using13 NH3 ammo-
nia; 20 mCi of 13NH3 in 5 ml of saline solution followed by a
20 ml flush of saline solution was slowly infused at a constant
rate of 10 ml/min. Acquisition was started simultaneously with
the injection of 13NH3. In each patient, 19 dynamic frames
were recorded (12 frames 3 10 s, 4 3 30 s, 3 3 2 min). Total
acquisition time was 10 min.
Regional myocardial utilization of exogenous glucose was
evaluated with 18F deoxyglucose (FDG). The metabolic studies
were performed by using the euglycemic hyperinsulinemic
clamp technique (17,18). Ten millicuries was injected 50 min
after 13NH3 injection. In each patient, 22 dynamic frames were
recorded (8 frames 3 15 s, 4 3 30 s, 2 3 1 min, 2 3 2 min, 6 3
10 min). Acquisition time was 70 min.
The 19 frames of the perfusion studies and the 22 frames of
the metabolic studies were reconstructed, PET data were
delineated and represented by using polar maps, using the
central values between endocardial and epicardial contours, to
minimize spillover from surrounding regions. (Using the max-
Abbreviations and Acronyms
CAD 5 coronary artery disease
ECG 5 electrocardiogram
EF 5 ejection fraction
FDG 5 18F deoxyglucose
LAD 5 left anterior descending coronary artery
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PET 5 positron emission tomography
ROI 5 region of interest
SPECT 5 single-photon emission computed tomography
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imal value would result in increased spillover from the blood
pool in the earlier frames [19].) Each polar map was divided
into 33 sectors: 4 rings of 8 sectors and 1 sector for the apex.
The average of the two sectors covering the region from which
the biopsy specimen was taken (anterior wall) was used for
further analysis (two shaded sectors in Fig. 1). To calculate
absolute flow values from the tracer uptake curves of this
region, a three-compartment model was applied (20,21). After
absolute flow values were obtained with this model, a flow
index was calculated as the ratio of the flow in the biopsy
region divided by flow in the reference sector (no stenosis or
stenosis ,50% in the left circumflex or right coronary artery).
Segments with flow values .80% of the flow value in the
reference sector (flow index .0.8) were considered normal.
Regional glucose utilization values were estimated by ap-
plying a Patlak graphic analysis (22,23). The sector in which
flow was considered to be normal was used as reference for
FDG. A metabolic index, that is, the ratio of the glucose
utilization in the biopsy region over that in the reference
sector, was calculated.
Regions were defined as PET viable when the flow index
was .0.8 or when the ratio of metabolic and flow index was
.1.2. Regions were defined as PET nonviable when the flow
index was,0.8 and when the ratio of metabolic and flow index
was lower than 1.2. This criterion was previously established in
normal volunteers (13,24,25).
Rest 99mTc MIBI SPECT studies. Patients underwent rest
99mTc MIBI SPECT studies 1 or 2 days before and 3 months
after operation. 99mTc MIBI, 15 mCi, was injected at rest
60 min before the start of acquisition and flushed with 10 ml of
saline solution. Approximately 10 min after injection, patients
drank 20 cl of whole milk to enhance hepatic clearance of the
isotope. The studies were performed on a three-head system
(Trionix Triad XLT). Images were acquired with a ultrahigh
resolution parallel hole collimator. The camera was rotated
over a 1208 orbit; and 24 projection images per head (1
min/projection) were obtained, resulting in 72 projections over
3608. A 20% window centered on the 140-ke V peak was used.
The raw MIBI projections were processed with a two-
dimensional Butterworth filter with a 0.52 cutoff and an order
of 5, and reconstructed with a ramp filter. No attenuation
correction was performed.
The MIBI images were delineated with the same procedure
applied to the PET images, and polar maps were constructed
by using the maximal pixel value between the endocardial and
epicardial contours (19). For quantification of the results, the
counts in the polar maps were normalized to the maximal value
of the entire map. Because the polar maps have the same size
and orientation as the PET flow and metabolic maps, the same
region used in the PET studies (two shaded sectors in Fig. 1)
was applied to the MIBI map, and the mean value of that
region was used for further analysis of 99mTc MIBI uptake.
Microscopic examination. During operation, one transmu-
ral biopsy specimen was taken from the anterior wall of the left
ventricle, approximately 4 cm from the apex, between the distal
LAD and the last diagonal branch (Tru-Cut biopsy needle,
Travenol Laboratories). The specimen was fixed in glutaralde-
hyde, postfixed in an OsO4 solution and routinely embedded in
epoxy resin. From each endocardial and epicardial part, semi-
thick sections (2 mm) were examined with light microscopy.
These results were pooled, because resolution of both PET and
MIBI images preclude differentiation between the endocardial
and epicardial parts of the myocardium. To assess the amount
of connective tissue in the myocardium, a grid consisting of
vertical and horizontal lines providing 121 intersections
(points) was used. This morphometric technique has been used
in previous studies (13,26,27). Counting the number of points
overlying a certain structure results in quantitative determina-
tion of the volume of the structure under investigation in
relation to the volume of the entire tissue under the square
grid. The total number of points was regarded as 100%, and
the points counted in the connective tissue were expressed as
the percent of the entire tissue within the limits of the grid. The
axis of the grid was then rotated ;458 and the same procedure
was repeated. The analysis was reperformed on a different area
of the same section. Longitudinal sections at magnification
3250 were evaluated.
Statistical analysis. Results are given as mean value6 SD.
Differences between groups were investigated by using Student
t tests for paired data. For evaluation of the relation between
Tc99m sestamibi uptake or normalized PET flow and percent
fibrosis, linear regression plots were used. Differences between
correlation coefficients were tested by using Fisher z transfor-
mations. Positive predictive values, negative predictive values,
sensitivity and specificity were calculated. To calculate an
optimal threshold for MIBI (100 2 %false positive 2 %false
negative) was maximized.
Results
Study patients. Thirty patients (25 men and 5 women with
a mean age 6 SD of 63 6 14 years) with severe stenosis of the
LAD ($70%) were prospectively included (Table 1). Coronary
artery bypass surgery was scheduled for 22 of the 30 patients
because of stable angina, for 5 because of unstable angina and
for 3 because of heart failure. Four patients had had a previous
anterior infarction. Preoperatively, the contrast ventriculo-
gram revealed regional hypokinesia in 8, severe hypokinesia in
Figure 1. Example of a positron emission tomographic (PET) and
99mTc sestamibi (MIBI) polar map. There is a known 1:1 correspon-
dence between sectors in the polar map and sectors in the delineated
left ventricular wall. The shaded sectors are defined as the biopsy area;
the mean value of this region was used for further analysis. A 5
anterior; I 5 inferior; L 5 lateral; S 5 septal.
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12 and akinesia or dyskinesia in 10 patients. Global and
regional EF was followed up postoperatively with radionuclide
angiography in 27 patients; in 13 global EF was improved and
in 16, regional contractile function was improved. An electro-
cardiogram (ECG) was performed preoperatively and imme-
diately after bypass surgery in all patients. If an ECG change
was observed, cardiac enzymes were measured. With use of
this routine procedure, no perioperative myocardial infarction
was discovered in the study patients. In 5 of the 30 patients no
MIBI imaging was performed and in 4 no PET images were
acquired, owing to time constraints before scheduled cardiac
surgery. Three patients refused follow-up measurements of left
ventricular function.
Agreement between MIBI and different viability tracers.
We first examined the general agreement between 99mTc MIBI
findings and the results of PET, histologic studies and func-
tional recovery studies.
99mTc MIBI percent of peak values was compared for
PET-viable and PET-nonviable groups. Statistically significant
higher MIBI values were found in the PET-viable than in the
PET nonviable group (77 6 15% [n 5 6] vs. 53 6 22% [n 5
15], p 5 0.02). A linear relation was found between MIBI
uptake and PET-normalized 13NH3 uptake values (y5 0.92x1
0.05, y 5 MIBI uptake, x 5 PET-normalized 13NH3 uptake,
n 5 21, r 5 0.83, p , 0.0001).
The percent fibrosis versus 99mTc MIBI percent of peak
activity is represented in Figure 2. A significant inverse linear
relation was found between MIBI uptake and the amount of
fibrotic tissue in the biopsy specimen (y 5 20.73x 1 81; y 5
percent fibrosis, x 5 MIBI uptake, n 5 25, r 5 0.78, p ,
0.00001). A similar relation was also observed between nor-
malized PET perfusion data and percent fibrosis (y 5
20.88x 1 89, y 5 percent fibrosis, x 5 PET flow index, n 5 26,
r 5 0.79, p , 0.00001) (Fig. 2). No significant difference was
found between the correlation coefficients of both curves (p 5
NS).
Figure 3 shows 99mTc MIBI percent of peak activity for the
patients with functional recovery and for those who had no
improvement in regional left ventricular function. Significantly
higher MIBI values were found in the group with enhanced






(ml/min per 100 g)
Absolute PET
Glucose Uptake
(mmol/min per 100 g)
MIBI
(% max)
Regional EF (%) Global EF (%)
Fibrosis
(%)Preop 3 mo Preop 3 mo
1 80 55 33 49 43 41 36 36 19
2 90 65 39 54 22 26 32 37 49
3 90 52 71 49 66 42 50 30
4 90 44 30 25 31 26 38 34 43
5 80 23 13 19 17 37 79
6 90 38 21 44 27 43 26 73
7 70 58 33 80 43 52 65 73 35
8 TO 65 56 39 45 46 48 40
9 70 72 47 81 49 44 68 72 26
10 70 77 36 53 51 28
11 TO 57 52 49 25 62 36 40 17
12 80 67 28 84 67 75 72 79 23
13 80 60 43 70 31 35 42 39 36
14 90 38 16 25 28 17 31 23 88
15 90 19 9 36 24 36 65
16 90 66 51 88 63 70 52 54 10
17 STO 59 61 41 52 63 67 16
18 STO 39 12 36 25 21 35 29 58
19 90 32 21 38 17 15 31 27 49
20 80 85 49 72 47 55 52 55 27
21 70 86 46 59 55 61 9
22 70 66 38 46 41 47 39
23 80 83 56 76 47 42 51 48 25
24 STO 54 42 89 35 49 31 40 18
25 90 81 29 35 40 43 49
26 90 64 37 50 43 37 44 41 38
27 80 84 44 65 64 73 23
28 80 97 96 80 61 53 64 66 11
29 90 60 46 66 45 40 50 46 29
30 80 90 54 85 44 51 47 53 10
EF 5 ejection fraction; LAD 5 left anterior descending coronary artery; MIBI (% max) 5 99mTc sestamibi percent of peak activity; PET 5 positron emission
tomography; PET flow 5 absolute regional myocardial blood flow; PET glucose 5 absolute myocardial glucose uptake; Preop 5 before coronary artery bypass surgery;
Pt. 5 patient; STO 5 subtotal occlusion; TO 5 total occlusion; 3 mo 5 3 months after coronary artery bypass surgery.
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regional EF at 3 months (99mTc MIBI uptake 76 6 13% [n 5
13] vs. 53 6 22% [n 5 10], p , 0.01). Similar results were
obtained when analyzing MIBI uptake in relation to global EF
(99mTc MIBI uptake 766 14% [n5 11] vs. 566 22% [n5 12],
p , 0.05).
In Table 1, PET absolute regional myocardial blood flow
and glucose uptake, percent MIBI uptake, percent fibrosis and
functional evolution (regional EF and global EF) are plotted
for each patient.
Predictive value of MIBI as viability tracer (Table 2).
Because, by inclusion criteria, the left ventricular anterior wall
was hypoakinetic or akinetic in each patient and because the
biopsy specimen was taken from the anterior wall (4 cm from
the apex) and MIBI values in the anterior wall were used for
analysis, we used the evolution of regional EF as the reference
standard to calculate an optimal threshold for MIBI. This
threshold was calculated by maximizing (100 2 % false posi-
tives 2 % false negatives). With this criterion, an optimal
threshold of 50% was found. Significantly less fibrosis was
found in the group with.50%MIBI uptake than in those with
#50% MIBI uptake (p , 0.01, Fig. 4). When the 50%
threshold was applied to the study, the positive predictive value
was 82% and the negative predictive value was 78% (n 5 23).
In a study employing 201Tl (28), a 50% cutoff was also found to
be a valid value for viability assessment when quantitating 201Tl
uptake for prediction of improved function.
In contrast, positive and negative predictive values of 91%
Figure 2. Percent fibrosis in anterior wall biopsy specimen versus
99mTc sestamibi (Mibi) (left) and versus normalized 13NH3 uptake (rel
PET flow) (right). Mibi % of max 5 99mTc sestamibi percent of peak
activity. Open circles indicate individual data points.
Figure 3. 99mTc sestamibi (Mibi) uptake correlated with observed
improvement or no improvement of regional ejection fraction. % of
max 5 percent of peak activity. Open circles indicate individual data
points.














Viable anterior wall areas 10 1
Nonviable anterior wall areas 2 10
*Defined as improvement in regional ejection fraction. †50% was the
optimal threshold for this study by maximizing (100 2%false positives 2%false
negatives). MIBI 5 99mTc sestamibi percent of peak activity .50% or #50%;
13NH35 normalized positron emission tomography (PET) flow.50% or#50%;
pts. 5 patients; other abbreviations as in Table 1.
Figure 4. Percent fibrosis in anterior wall biopsy specimen in regions
with 99mTc sestamibi (Mibi) uptake .50% and #50% of peak activity.
Open circles indicate individual data points.
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and 83%, respectively, were found for the PET match/
mismatch model, with a sensitivity of 83% and a specificity of
91%. Additionally, predictive values for 13NH3 flow for pre-
diction of improved function were separated out from the
overall PET criteria of flow and glucose uptake for viability.
With use of the same formula as described earlier (maximizing
100 2 %false positives 2 %false negatives), a threshold of
50% was found, resulting in positive and negative predictive
values of 69% and 86% respectively, with a sensitivity of 92%
and a specificity of 55%.
Discussion
In this study, we examined whether 99mTc MIBI can play a
role in the assessment of myocardial viability. Statistically
significant higher MIBI uptake values were found in areas with
PET-assessed myocardial viability and in regions that revealed
improvement of left ventricular function 3 months after coro-
nary artery bypass surgery, suggesting a possible role for MIBI
as viability tracer. Moreover, a linear relation was found
between percent fibrosis and MIBI uptake (r 5 0.78). In a
recent study (29), a similar linear relation was found between
percent fibrosis and thallium activity after tracer reinjection
(r 5 0.85), whereas the correlation between thallium activity
and fibrosis was lower when only conventional redistribution
images were considered (r 5 0.62). These data suggest that
quantitative analysis of regional activity of 99mTc MIBI after
rest injection provides information on the amount of intersti-
tial fibrosis comparable to that of regional activity of 201Tl after
reinjection. A significant relation between the amount of
connective tissue in the biopsy specimen and PET-normalized
flow values was found (r 5 0.79), suggesting that perfusion
levels alone, as traced by 13NH3, are also an indicator of the
amount of fibrotic tissue. This finding is in concordance with
the hypothesis (30) that hibernating myocardium is the result
of repetitive episodes of ischemia with a persistent stunning
effect and normal or near normal blood flow values in the
hypocontractile area. It has also been shown (31) that reten-
tion of 13NH3 requires the presence of viable myocardial cells.
When we considered recovery of regional left ventricular
function as a reference standard for viability, we found an
optimal threshold of 50% for MIBI, resulting in positive and
negative predictive values of 82% and 78%, respectively. This
finding is in concordance with previous studies (32–34) indi-
cating that MIBI kinetics appear to depend on cell membrane
integrity and mitochondrial respiration. When a threshold is
used to assess myocardial “viability,” it is necessary to recog-
nize that myocardial viability is a continuum (35). Myocardial
segments with decreased tracer uptake may contain a substan-
tial amount of viable myocardium. The 50% threshold used
relates to the likelihood of improvement of regional wall
motion after revascularization.
Concerning the comparison between PET flow imaging and
99mTc MIBI for the detection of viability, relatively low spec-
ificity values were found for both when using a cutoff value of
50%. This finding is in agreement with recent work (36)
indicating that functional recovery can be predicted when
using 13NH3 at low uptake (,40%) and high uptake (.80%)
values, whereas intermediate normalized flow values necessi-
tate additional information regarding glucose or oxidative
metabolism to estimate accurately the potential for recovery.
Positive and negative predictive values for PET NH3/FDG
imaging in this study were higher (83% and 91%, respectively)
than the values for 13NH3 alone and the values for
99mTc
MIBI, indicating an added value for the NH3/FDG match/
mismatch model for the detection of viable segments. How-
ever, one should also consider the limited availability of PET
centers or cyclotron sites and the relatively high cost of the
investigation.
The most important limitation of this study is that it is not
absolutely certain that myocardial anterior wall segments
defined by the MIBI SPECT studies correspond exactly to the
PET segments and that histologic results derived from a small
biopsy specimen (;15 mg) can be extrapolated to data on
metabolism, flow and function for much larger areas. However,
the three-dimensional delineation of both MIBI and PET
images resulted in accurate mapping of the anatomic location
of each region. It should also be noted that our data apply only
to patients with CAD in whom viability of the anterior wall is
being assessed.
From the preceding analysis, one may conclude that the
level of 99mTc MIBI uptake is linearly related to the amount of
interstitial fibrosis. When using left ventricular functional
improvement as the standard for viability, we found an optimal
threshold of 50% for MIBI with positive and negative predic-
tive values of 82% and 78%, respectively. Therefore, the
present data indicate that MIBI reflects not only flow, but also,
at least in part, myocardial viability.
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